- Home
- Publications
- Publication Search
- Publication Details
Title
Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 7, Pages e102135
Publisher
Public Library of Science (PLoS)
Online
2014-07-11
DOI
10.1371/journal.pone.0102135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis
- (2014) R. C. Hartkoorn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism
- (2014) Anil Koul et al. Nature Communications
- Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor
- (2013) Shashank Gupta et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efflux Inhibition with Verapamil Potentiates Bedaquiline in Mycobacterium tuberculosis
- (2013) Shashank Gupta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis
- (2013) Thomas R. Ioerger et al. PLoS One
- Approval of Novel TB Drug Celebrated--With Restraint
- (2013) J. Cohen SCIENCE
- Sterilizing Activities of Novel Combinations Lacking First- and Second-Line Drugs in a Murine Model of Tuberculosis
- (2012) Kathy Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
- (2012) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Mutations in the Mycobacterial ATP Synthase: New Insights into the Binding of the Diarylquinoline TMC207 to the ATP Synthase C-Ring Structure
- (2012) Elena Segala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Antibiotic Resistance Arrow of Time: Efflux Pump Induction Is a General First Step in the Evolution of Mycobacterial Drug Resistance
- (2012) Aurelia M. Schmalstieg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistantMycobacterium tuberculosisthrough Efflux
- (2011) Gail E. Louw et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efflux as a mechanism for drug resistance inMycobacterium tuberculosis: Table 1
- (2011) Pedro Eduardo Almeida da Silva et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis
- (2010) J. E. M. de Steenwinkel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Rates and Mechanisms of Resistance Development in Mycobacterium tuberculosis to a Novel Diarylquinoline ATP Synthase Inhibitor
- (2009) E. Huitric et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5–MmpL5 efflux system
- (2008) Anna Milano et al. TUBERCULOSIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started